• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Research Data
  • Organizations
  • Researchers
  • More
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy.
 

The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy.

Options
  • Details
  • Files
BORIS DOI
10.48350/199865
Publisher DOI
10.1007/s41999-024-01036-4
PubMed ID
39162972
Description
PURPOSE

To explore the association between medication use-related factors and health-related quality of life (HRQoL) in older hospitalised multimorbid patients with polypharmacy.

METHODS

This cross-sectional study used the intervention arm data of the OPERAM trial (hospitalised patients ≥ 70 years with polypharmacy). HRQoL was assessed using the visual analogue scale (EQ-VAS) and the EQ-5D index score of the EuroQol questionnaire (EQ-5D-5L). Lower or higher EQ-VAS/EQ-5D was based on the median of the study population. Medication use-related factors included hyperpolypharmacy (≥ 10 medications), anticholinergic and sedative burden, appropriateness of medication (STOPP/START criteria), high-risk medication for hospital (re)admission, medication complexity and adherence. Multivariable logistic regression analysis was used to assess the association between medication use-related factors and HRQoL.

RESULTS

A total of 955 patients were included (mean age 79 years, 46% female, median EQ-VAS of 60, median EQ-5D of 0.60). Opioids use was associated with lower EQ-5D and EQ-VAS (aOR EQ-5D: 2.10; 95% CI 1.34-3.32, EQ-VAS: 1.59; 1.11-2.30). Hyperpolypharmacy (aOR 1.37; 1.05-1.80), antibiotics (aOR 1.64; 1.01-2.68) and high medication complexity (aOR 1.53; 1.10-2.15) were associated with lower EQ-VAS. A high anticholinergic and sedative burden (aOR 1.73; 1.11-2.69), presence of multiple prescribing omissions (aOR 1.94; 1.19-3.17) and benzodiazepine use (aOR 2.01; 1.22-3.35) were associated with lower EQ-5D. Especially in hyperpolypharmacy patients, high anticholinergic and sedative burden and medication complexity were associated with a lower HRQoL.

CONCLUSION

Several medication use-related factors are significantly associated with a lower HRQoL in hospitalised older patients. Medication complexity is a novel factor, which should be considered when evaluating medication use of older patients with hyperpolypharmacy.
Date of Publication
2024-08-20
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
300 - Social sciences, sociology & anthropology::360 - Social problems & social services
Keyword(s)
HRQoL Medication complexity Medication use Polypharmacy Quality of life
Language(s)
en
Contributor(s)
Falke, Charlotte
Karapinar, Fatma
Bouvy, Marcel
Emmelot, Mariëlle
Belitser, Svetlana
Boland, Benoit
O'Mahony, Denis
Murphy, Kevin D
Haller, Moa
Institute of General Practice and Primary Care (BIHAM)
Clinic of General Internal Medicine
Salari, Paola
Schwenkglenks, Matthias
Rodondi, Nicolas
Universitätsklinik für Allgemeine Innere Medizin
Berner Institut für Hausarztmedizin (BIHAM)
Egberts, Toine
Knol, Wilma
Additional Credits
Institute of General Practice and Primary Care (BIHAM)
Universitätsklinik für Allgemeine Innere Medizin
Series
European Geriatric Medicine
Publisher
Springer
ISSN
1878-7649
Related Funding(s)
Horizon2020
Swiss State Secretariat for Education, Research and Innovation (SERI)
Related URL(s)
https://doi.org/10.48620/77183
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: ae9592 [15.12. 16:43]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo